$SMCE
SMC Entertainment, Inc.

2024 Q2 Form 10-Q Financial Statement

#000165495424006185 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $30.00K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $488.1K $204.9K $186.6K
YoY Change 106.27% 9.78%
Operating Profit -$488.1K -$204.9K -$186.6K
YoY Change 106.27% 9.78%
Interest Expense $52.31K $15.75K $7.956K
YoY Change 856.34% 97.98%
% of Operating Profit
Other Income/Expense, Net -$14.13M $360.7K -$244.3K
YoY Change 11435.21% -247.66%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$14.62M $155.8K -$430.9K
YoY Change 1338.81% -136.16% -64.64%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 1.474B shares 1.316B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.420K $4.220K
YoY Change -96.54%
Cash & Equivalents $1.418K $4.222K $2.350K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $300.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.418K $304.2K
YoY Change -99.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $64.19K $64.19K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $93.79K $64.19K
YoY Change 46.11%
TOTAL ASSETS
Total Short-Term Assets $1.418K $304.2K
Total Long-Term Assets $93.79K $64.19K
Total Assets $95.21K $368.4K
YoY Change -76.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $78.22K $88.72K
YoY Change -17.56%
Accrued Expenses $1.769K $969.9K
YoY Change -99.85%
Deferred Revenue
YoY Change
Short-Term Debt $10.05M $1.990M
YoY Change 719.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.23M $3.465M
YoY Change 441.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $17.23M $3.465M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $17.23M $3.465M
YoY Change 441.57%
SHAREHOLDERS EQUITY
Retained Earnings -$32.02M -$17.40M
YoY Change 90.73%
Common Stock $1.353M $1.474M
YoY Change 16.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.13M -$3.096M -$2.616M
YoY Change
Total Liabilities & Shareholders Equity $95.21K $368.4K
YoY Change -76.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$14.62M $155.8K -$430.9K
YoY Change 1338.81% -136.16% -64.64%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$68.58K -$13.00K -$13.31K
YoY Change -3.65% -2.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 65.78K $9.954K $13.31K
YoY Change -40.16% -25.23%
NET CHANGE
Cash From Operating Activities -68.58K -$13.00K -$13.31K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities 65.78K $9.954K $13.31K
Net Change In Cash -2.800K -$3.047K $0.00
YoY Change -107.23%
FREE CASH FLOW
Cash From Operating Activities -$68.58K -$13.00K -$13.31K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Significant estimates include the fair value for derivatives. Actual results could differ from those estimates.</p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).</p>
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001497230
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1379960743 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1379960743 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-56558
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SMC Entertainment, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
59170 Glades
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Road Suite 150
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33434
CY2024Q1 dei City Area Code
CityAreaCode
360
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
820-5973
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1473960743 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4222 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7269 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
300000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
300000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
304222 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
307269 usd
CY2024Q1 us-gaap Goodwill
Goodwill
64194 usd
CY2023Q4 us-gaap Goodwill
Goodwill
64194 usd
CY2024Q1 us-gaap Assets
Assets
368416 usd
CY2023Q4 us-gaap Assets
Assets
371463 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
88719 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87887 usd
CY2024Q1 smc Accrued Compensation
AccruedCompensation
489125 usd
CY2023Q4 smc Accrued Compensation
AccruedCompensation
1486335 usd
CY2024Q1 smc Due To Related Parties
DueToRelatedParties
22430 usd
CY2023Q4 smc Due To Related Parties
DueToRelatedParties
22394 usd
CY2024Q1 smc Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
1111460 usd
CY2023Q4 smc Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
856187 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
846269 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
480815 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
465064 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
416128 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
792575 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3464864 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3700524 usd
CY2024Q1 us-gaap Liabilities
Liabilities
3464864 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3700524 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1379960743 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1379960743 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1473961 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1379961 usd
CY2024Q1 smc Discount For Series B Preferred Stock
DiscountForSeriesBPreferredStock
-24967500 usd
CY2023Q4 smc Discount For Series B Preferred Stock
DiscountForSeriesBPreferredStock
-24967500 usd
CY2024Q1 smc Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2023Q4 smc Common Stock To Be Issued
CommonStockToBeIssued
22000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12800975 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12796175 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17404874 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17560687 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3096448 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3329061 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
368416 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371463 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87083 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42275 usd
CY2024Q1 smc Compensation Expense Related Party
CompensationExpenseRelatedParty
117800 usd
CY2023Q1 smc Compensation Expense Related Party
CompensationExpenseRelatedParty
144350 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
204883 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
186625 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-204883 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-186625 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
15751 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
7956 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
376447 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-236326 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
360696 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-244282 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
155813 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-430907 usd
CY2024Q1 smc Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
0.00
CY2023Q1 smc Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2024Q1 smc Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
1425718985 shares
CY2023Q1 smc Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
1002634067 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3329061 usd
CY2024Q1 smc Common Stock Issued For Services Related Party Amount
CommonStockIssuedForServicesRelatedPartyAmount
1800 usd
CY2024Q1 smc Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
75000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
155813 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3096448 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2355358 usd
CY2023Q1 smc Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
158639 usd
CY2023Q1 smc Common Stock Issued For Services Related Party
CommonStockIssuedForServicesRelatedParty
4350 usd
CY2023Q1 smc Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
15000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-430907 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2608276 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
155813 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-430907 usd
CY2024Q1 smc Stock Issued During Common Stock Issued For Services Related Party
StockIssuedDuringCommonStockIssuedForServicesRelatedParty
1800 usd
CY2023Q1 smc Stock Issued During Common Stock Issued For Services Related Party
StockIssuedDuringCommonStockIssuedForServicesRelatedParty
4350 usd
CY2024Q1 smc Common Stock Issued For Services
CommonStockIssuedForServices
75000 usd
CY2023Q1 smc Common Stock Issued For Services
CommonStockIssuedForServices
15000 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
376447 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-236326 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
832 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13962 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
15751 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
7957 usd
CY2024Q1 smc Increase Decrease Accrued Compensation Releted Party
IncreaseDecreaseAccruedCompensationReletedParty
114250 usd
CY2023Q1 smc Increase Decrease Accrued Compensation Releted Party
IncreaseDecreaseAccruedCompensationReletedParty
140000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13001 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13312 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
36 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
9918 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
13312 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9954 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13312 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3047 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7269 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2350 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4222 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2350 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates its convertible notes to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. </p>
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
846269 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
9918 usd
CY2024Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
856187 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
536399 usd
CY2023 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-231367 usd
CY2023 smc Gain Loss On Derivative Gain Due To Mark To Market Adjustment
GainLossOnDerivativeGainDueToMarkToMarketAdjustment
487543 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
792575 usd
CY2024Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
0 usd
CY2024Q1 smc Gain Loss On Derivative Gain Due To Mark To Market Adjustment
GainLossOnDerivativeGainDueToMarkToMarketAdjustment
-376447 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
416128 usd

Files In Submission

Name View Source Status
0001654954-24-006185-index-headers.html Edgar Link pending
0001654954-24-006185-index.html Edgar Link pending
0001654954-24-006185.txt Edgar Link pending
0001654954-24-006185-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smc-20240331.xsd Edgar Link pending
smc_10q.htm Edgar Link pending
smc_ex311.htm Edgar Link pending
smc_ex312.htm Edgar Link pending
smc_ex321.htm Edgar Link pending
smc-20240331_cal.xml Edgar Link unprocessable
smc-20240331_def.xml Edgar Link unprocessable
smc-20240331_lab.xml Edgar Link unprocessable
smc-20240331_pre.xml Edgar Link unprocessable
smc_10q_htm.xml Edgar Link completed